{"id":9310,"date":"2026-05-27T09:50:15","date_gmt":"2026-05-27T07:50:15","guid":{"rendered":"https:\/\/www.salus.eu\/?p=9310"},"modified":"2026-05-27T09:50:18","modified_gmt":"2026-05-27T07:50:18","slug":"salus-v-partnerstvu-z-oncopeptides","status":"publish","type":"post","link":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/","title":{"rendered":"Salus v partnerstvu z Oncopeptides"},"content":{"rendered":"\n<p>Salus z veseljem najavlja partnerstvo s podjetjem Oncopeptides, s katerim bomo raz\u0161irili dostop do inovativnega zdravila Pepaxti\u00ae na obmo\u010dju srednje in vzhodne Evrope.<\/p>\n\n\n\n<p>Pepaxti\u00ae predstavlja ciljno terapijo za bolnike z multiplim mielomom, ki so iz\u010drpali obstoje\u010de mo\u017enosti zdravljenja. Gre za \u017ee v celoti odobreno terapijo, ki postaja vse bolj dostopna tudi bolnikom v na\u0161i regiji.<\/p>\n\n\n\n<p>Multipli mielom ne pozna meja, vendar dostop do sodobnih oblik zdravljenja pogosto ostaja omejen prav zaradi njih. V dr\u017eavah srednje in vzhodne Evrope razkorak med regulativno odobritvijo zdravila in njegovo dejansko dostopnostjo za bolnike lahko traja ve\u010d let. Razli\u010dni sistemi povra\u010dil stro\u0161kov, raznolika dinamika trgov ter specifi\u010dni regulativni postopki v posameznih dr\u017eavah ustvarjajo zamike, ki imajo lahko resne posledice za bolnike.<\/p>\n\n\n\n<p>Prav zapolnjevanje tega razkoraka je temeljno poslanstvo skupine Salus. \u017de desetletja sistemati\u010dno izbolj\u0161ujemo dostop do sodobnih terapij \u2013 od trga do trga, od terapije do terapije. \u010ceprav to pogosto pomeni soo\u010danje z zahtevnimi izzivi, ostajamo zavezani cilju, da inovativna zdravljenja \u010dim prej dose\u017eejo bolnike, ki jih potrebujejo.<\/p>\n\n\n\n<p>Partnerstvo z Oncopeptides tako predstavlja pomemben korak naprej pri uresni\u010devanju tega cilja in krepi na\u0161e prizadevanje za ve\u010djo dostopnost inovativnih onkolo\u0161kih terapij v regiji.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Salus z veseljem najavlja partnerstvo s podjetjem Oncopeptides, s katerim bomo raz\u0161irili dostop do inovativnega zdravila Pepaxti\u00ae na obmo\u010dju srednje in vzhodne Evrope. Pepaxti\u00ae predstavlja ciljno terapijo za bolnike z multiplim mielomom, ki so iz\u010drpali obstoje\u010de mo\u017enosti zdravljenja. Gre za \u017ee v celoti odobreno terapijo, ki postaja vse bolj dostopna tudi bolnikom v na\u0161i regiji. [&hellip;]<\/p>\n","protected":false},"author":39,"featured_media":9313,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-9310","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-novice"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Salus v partnerstvu z Oncopeptides &#8211; Salus<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/\" \/>\n<meta property=\"og:locale\" content=\"sl_SI\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Salus v partnerstvu z Oncopeptides &#8211; Salus\" \/>\n<meta property=\"og:description\" content=\"Salus z veseljem najavlja partnerstvo s podjetjem Oncopeptides, s katerim bomo raz\u0161irili dostop do inovativnega zdravila Pepaxti\u00ae na obmo\u010dju srednje in vzhodne Evrope. Pepaxti\u00ae predstavlja ciljno terapijo za bolnike z multiplim mielomom, ki so iz\u010drpali obstoje\u010de mo\u017enosti zdravljenja. Gre za \u017ee v celoti odobreno terapijo, ki postaja vse bolj dostopna tudi bolnikom v na\u0161i regiji. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/\" \/>\n<meta property=\"og:site_name\" content=\"Salus\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-27T07:50:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-27T07:50:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.salus.eu\/wp-content\/uploads\/2026\/05\/Oncopeptides-26.5.2026-1024x1024.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"simona_maric\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"simona_maric\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuta\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/2026\\\/05\\\/salus-v-partnerstvu-z-oncopeptides\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/2026\\\/05\\\/salus-v-partnerstvu-z-oncopeptides\\\/\"},\"author\":{\"name\":\"simona_maric\",\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/#\\\/schema\\\/person\\\/414d210b0be74a71b35a0361c20feeba\"},\"headline\":\"Salus v partnerstvu z Oncopeptides\",\"datePublished\":\"2026-05-27T07:50:15+00:00\",\"dateModified\":\"2026-05-27T07:50:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/2026\\\/05\\\/salus-v-partnerstvu-z-oncopeptides\\\/\"},\"wordCount\":211,\"publisher\":{\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/2026\\\/05\\\/salus-v-partnerstvu-z-oncopeptides\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.salus.eu\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Oncopeptides-26.5.2026.png\",\"articleSection\":[\"Novice\"],\"inLanguage\":\"sl-SI\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/2026\\\/05\\\/salus-v-partnerstvu-z-oncopeptides\\\/\",\"url\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/2026\\\/05\\\/salus-v-partnerstvu-z-oncopeptides\\\/\",\"name\":\"Salus v partnerstvu z Oncopeptides &#8211; Salus\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/2026\\\/05\\\/salus-v-partnerstvu-z-oncopeptides\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/2026\\\/05\\\/salus-v-partnerstvu-z-oncopeptides\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.salus.eu\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Oncopeptides-26.5.2026.png\",\"datePublished\":\"2026-05-27T07:50:15+00:00\",\"dateModified\":\"2026-05-27T07:50:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/2026\\\/05\\\/salus-v-partnerstvu-z-oncopeptides\\\/#breadcrumb\"},\"inLanguage\":\"sl-SI\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.salus.eu\\\/sl\\\/2026\\\/05\\\/salus-v-partnerstvu-z-oncopeptides\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sl-SI\",\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/2026\\\/05\\\/salus-v-partnerstvu-z-oncopeptides\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.salus.eu\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Oncopeptides-26.5.2026.png\",\"contentUrl\":\"https:\\\/\\\/www.salus.eu\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Oncopeptides-26.5.2026.png\",\"width\":1200,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/2026\\\/05\\\/salus-v-partnerstvu-z-oncopeptides\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Salus v partnerstvu z Oncopeptides\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/#website\",\"url\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/\",\"name\":\"Salus\",\"description\":\"Dobro ljudi je najvi\u0161ji zakon\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sl-SI\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/#organization\",\"name\":\"Salus\",\"url\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sl-SI\",\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.salus.eu\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/salus-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.salus.eu\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/salus-logo.png\",\"width\":300,\"height\":84,\"caption\":\"Salus\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/salus-ljubljana-d.d.\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.salus.eu\\\/sl\\\/#\\\/schema\\\/person\\\/414d210b0be74a71b35a0361c20feeba\",\"name\":\"simona_maric\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sl-SI\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d3deeb60175eb08c7656ad6ff54d9e14b92be9732cca38616b792b414cbad3fc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d3deeb60175eb08c7656ad6ff54d9e14b92be9732cca38616b792b414cbad3fc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d3deeb60175eb08c7656ad6ff54d9e14b92be9732cca38616b792b414cbad3fc?s=96&d=mm&r=g\",\"caption\":\"simona_maric\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Salus v partnerstvu z Oncopeptides &#8211; Salus","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/","og_locale":"sl_SI","og_type":"article","og_title":"Salus v partnerstvu z Oncopeptides &#8211; Salus","og_description":"Salus z veseljem najavlja partnerstvo s podjetjem Oncopeptides, s katerim bomo raz\u0161irili dostop do inovativnega zdravila Pepaxti\u00ae na obmo\u010dju srednje in vzhodne Evrope. Pepaxti\u00ae predstavlja ciljno terapijo za bolnike z multiplim mielomom, ki so iz\u010drpali obstoje\u010de mo\u017enosti zdravljenja. Gre za \u017ee v celoti odobreno terapijo, ki postaja vse bolj dostopna tudi bolnikom v na\u0161i regiji. [&hellip;]","og_url":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/","og_site_name":"Salus","article_published_time":"2026-05-27T07:50:15+00:00","article_modified_time":"2026-05-27T07:50:18+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/www.salus.eu\/wp-content\/uploads\/2026\/05\/Oncopeptides-26.5.2026-1024x1024.png","type":"image\/png"}],"author":"simona_maric","twitter_card":"summary_large_image","twitter_misc":{"Written by":"simona_maric","Est. reading time":"1 minuta"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/#article","isPartOf":{"@id":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/"},"author":{"name":"simona_maric","@id":"https:\/\/www.salus.eu\/sl\/#\/schema\/person\/414d210b0be74a71b35a0361c20feeba"},"headline":"Salus v partnerstvu z Oncopeptides","datePublished":"2026-05-27T07:50:15+00:00","dateModified":"2026-05-27T07:50:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/"},"wordCount":211,"publisher":{"@id":"https:\/\/www.salus.eu\/sl\/#organization"},"image":{"@id":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/#primaryimage"},"thumbnailUrl":"https:\/\/www.salus.eu\/wp-content\/uploads\/2026\/05\/Oncopeptides-26.5.2026.png","articleSection":["Novice"],"inLanguage":"sl-SI"},{"@type":"WebPage","@id":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/","url":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/","name":"Salus v partnerstvu z Oncopeptides &#8211; Salus","isPartOf":{"@id":"https:\/\/www.salus.eu\/sl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/#primaryimage"},"image":{"@id":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/#primaryimage"},"thumbnailUrl":"https:\/\/www.salus.eu\/wp-content\/uploads\/2026\/05\/Oncopeptides-26.5.2026.png","datePublished":"2026-05-27T07:50:15+00:00","dateModified":"2026-05-27T07:50:18+00:00","breadcrumb":{"@id":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/#breadcrumb"},"inLanguage":"sl-SI","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/"]}]},{"@type":"ImageObject","inLanguage":"sl-SI","@id":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/#primaryimage","url":"https:\/\/www.salus.eu\/wp-content\/uploads\/2026\/05\/Oncopeptides-26.5.2026.png","contentUrl":"https:\/\/www.salus.eu\/wp-content\/uploads\/2026\/05\/Oncopeptides-26.5.2026.png","width":1200,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/www.salus.eu\/sl\/2026\/05\/salus-v-partnerstvu-z-oncopeptides\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.salus.eu\/sl\/"},{"@type":"ListItem","position":2,"name":"Salus v partnerstvu z Oncopeptides"}]},{"@type":"WebSite","@id":"https:\/\/www.salus.eu\/sl\/#website","url":"https:\/\/www.salus.eu\/sl\/","name":"Salus","description":"Dobro ljudi je najvi\u0161ji zakon","publisher":{"@id":"https:\/\/www.salus.eu\/sl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.salus.eu\/sl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sl-SI"},{"@type":"Organization","@id":"https:\/\/www.salus.eu\/sl\/#organization","name":"Salus","url":"https:\/\/www.salus.eu\/sl\/","logo":{"@type":"ImageObject","inLanguage":"sl-SI","@id":"https:\/\/www.salus.eu\/sl\/#\/schema\/logo\/image\/","url":"https:\/\/www.salus.eu\/wp-content\/uploads\/2019\/06\/salus-logo.png","contentUrl":"https:\/\/www.salus.eu\/wp-content\/uploads\/2019\/06\/salus-logo.png","width":300,"height":84,"caption":"Salus"},"image":{"@id":"https:\/\/www.salus.eu\/sl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/salus-ljubljana-d.d.\/"]},{"@type":"Person","@id":"https:\/\/www.salus.eu\/sl\/#\/schema\/person\/414d210b0be74a71b35a0361c20feeba","name":"simona_maric","image":{"@type":"ImageObject","inLanguage":"sl-SI","@id":"https:\/\/secure.gravatar.com\/avatar\/d3deeb60175eb08c7656ad6ff54d9e14b92be9732cca38616b792b414cbad3fc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d3deeb60175eb08c7656ad6ff54d9e14b92be9732cca38616b792b414cbad3fc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d3deeb60175eb08c7656ad6ff54d9e14b92be9732cca38616b792b414cbad3fc?s=96&d=mm&r=g","caption":"simona_maric"}}]}},"_links":{"self":[{"href":"https:\/\/www.salus.eu\/sl\/wp-json\/wp\/v2\/posts\/9310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.salus.eu\/sl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.salus.eu\/sl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.salus.eu\/sl\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/www.salus.eu\/sl\/wp-json\/wp\/v2\/comments?post=9310"}],"version-history":[{"count":0,"href":"https:\/\/www.salus.eu\/sl\/wp-json\/wp\/v2\/posts\/9310\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.salus.eu\/sl\/wp-json\/wp\/v2\/media\/9313"}],"wp:attachment":[{"href":"https:\/\/www.salus.eu\/sl\/wp-json\/wp\/v2\/media?parent=9310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.salus.eu\/sl\/wp-json\/wp\/v2\/categories?post=9310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.salus.eu\/sl\/wp-json\/wp\/v2\/tags?post=9310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}